BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cancer / Oncology

Japan to Encourages Breakthrough Cancer Research

Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Awar...

October 05, 2021 | News

Colorectal cancer diagnoses dropped over 40% during COVID-19 pandemic

The research, which was conducted across multiple hospitals in Spain, compared data from the first year of the COVID-19 pandemic with data from the pr...

October 04, 2021 | News

Zantrene® kills melanoma cancer cells that overproduce FTO

Zantrene® at low concentrations kills high FTO producing melanoma cancer cells Sensitivity to Zantrene® correlates with FTO levels, where high F...

September 30, 2021 | News

Singapore Approved New Therapy to Treat Advanced Small Cell Lung Cancer

ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20...

September 23, 2021 | News

New Zealand's Cancer Organisations Warn Of COVID Pandemic-led Drop In Cancer Being Diagnosed And Treated

Around 9,000 New Zealanders die of cancer every year.[2] New campaign launched today encourages people to get unusual and persistent symptoms chec...

September 20, 2021 | News

Satisfai Health acquires global license for AI software to detect early cancer in Barrett's Esophagus

Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy...

September 17, 2021 | News

FDA granted premarket approval to Thermo Fisher Scientific's Oncomine Dx Target Test

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations The U.S. Food and...

September 16, 2021 | News

Australia Approved New Therapy to Treat Advanced Small Cell Lung Cancer

Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-line metastatic SCLC in Australia in more tha...

September 15, 2021 | News

Taiwan to provide smart access to personalized cancer care

Varian, a Siemens Healthineers company, announced today that China Medical University Hospital in Central Taiwan treated its first patient with E...

September 13, 2021 | News

China strengthen it's Proton Therapy System

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research...

September 13, 2021 | News

Merck to Present Latest Highlights From Oncology Portfolio at WCLC and ESMO 2021

Merck, a leading science and technology company, today announced research from Company-sponsored, investigator-sponsored, and collaborative studies —...

September 13, 2021 | News

Illumina Partners with Merck to advance cancer diagnostics and precision medicine.

Illumina, Inc. (NASDAQ: ILMN) and Merck (known as MSD outside the United States and Canada) today announced a partnership to develop an...

September 08, 2021 | News

Dr. Reddy’s Lab to sell its rights to anti-cancer agent E7777

Under the terms of agreement, Dr. Reddy’s will receive $40 million upfront upon the closing of the transaction, followed by approval milestone paymen...

September 06, 2021 | News

Single Cell Discoveries joins consortium to build a single-cell cancer atlas to find therapy resistant tumor cells

This collaborative research program aims to provide the cancer research community with a new gold standard workflow for single-cell sequencing by developin...

September 02, 2021 | News

Stay Connected